Characterization of the IGF axis components in isolated rat hepatic stellate cells

被引:59
作者
Scharf, JG
Knittel, T
Dombrowski, F
Müller, L
Saile, B
Braulke, T
Hartmann, H
Ramadori, G
机构
[1] Univ Gottingen, Med Klin, Dept Med, Div Gastroenterol & Endocrinol, D-37075 Gottingen, Germany
[2] Univ Bonn, Inst Pathol, D-5300 Bonn, Germany
[3] Univ Gottingen, Dept Biochem 2, D-3400 Gottingen, Germany
关键词
D O I
10.1002/hep.510270513
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The insulin-like growth factors I and II (IGF-I, -II) are circulating peptides known to participate in the regulation of metabolism, growth, and cellular differentiation. In the present study, "early cultured" (days 2-3 of culture) and "culture-activated" (days 6-7 of culture) rat hepatic stellate cells (HSCs) were analyzed for expression of individual components of the IGF axis. Northern blot analysis of IGF-I messenger RNA (mRNA) revealed transcripts of 7.5, 4, 2, and 1.0 to 1.5 kb in culture-activated HSCs, while early cultured HSCs did not express IGF-I mRNA. In culture-activated HSCs, an IGF-I secretion of 8.3 +/- 2.5 ng/10(6) cells per 24 hours was determined radioimmunologically. In media from early cultured HSCs, IGF-I was not detectable. The IGF-I receptor (IGF-I-R) mRNA expression was threefold higher in early cultured HSCs than in culture-activated HSCs. By immunohistochemistry, a decrease of IGF-I-R expression of HSCs in vivo following CCl4-induced liver damage was noted as well. IGF binding proteins (IGFBPs) were detected in conditioned media from HSCs by I-125- IGF-I ligand blotting at apparent molecular masses of 24 and 41 to 45 kd that were immunologically identified as IGFBP-4 and -3, respectively Synthesis of these IGFBPs increased with time of culture. At neutral pH, no IGFBP proteolysis was observed in conditioned media of early cultured and culture-activated HSCs, whereas at acidic pH, protease activities against IGFBP-3 and -4 were detectable. IGFBP protease activities were completely abolished by inhibitors of aspartyl and cysteine proteases. Addition of 100 nmol/L IGF-I stimulated cell proliferation of early cultured HSCs 5.6 +/- 1.1- and 4.6 +/- 0.2-fold as measured by [H-3]thymidine and 5-bromo-2'-deoxyuridine incorporation, respectively In culture-activated HSCs, proliferation was increased 1.2 +/- 0.1-fold in the presence of 100 nmol/L IGF-I in both proliferation assays. It can be concluded that due to a higher expression of the IGF-I-R and lower levels of IGFBPs, early cultured HSCs are more susceptible to the mitogenic actions of IGFs than the culture-activated HSCs. The present data suggest a role for the IGF axis components in the initiation rather than the perpetuation of HSC proliferation during hepatic fibrogenesis.
引用
收藏
页码:1275 / 1284
页数:10
相关论文
共 59 条
[1]   DIFFERENTIAL CELLULAR SYNTHESIS OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 (IGFBP-1) AND IGFBP-3 WITHIN HUMAN LIVER [J].
ARANY, E ;
AFFORD, S ;
STRAIN, AJ ;
WINWOOD, PJ ;
ARTHUR, MJP ;
HILL, DJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1871-1876
[2]  
BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
[3]  
Braulke T, 1996, Subcell Biochem, V27, P15
[4]  
Braulke T, 1996, GROWTH REGULAT, V6, P55
[5]   IS MOVEMENT OF MANNOSE 6-PHOSPHATE-SPECIFIC RECEPTOR TRIGGERED BY BINDING OF LYSOSOMAL-ENZYMES [J].
BRAULKE, T ;
GARTUNG, C ;
HASILIK, A ;
VONFIGURA, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (06) :1735-1742
[6]  
Brenzel A, 1996, EUR J CLIN CHEM CLIN, V34, P401
[7]   PROTEOLYSIS OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-5 BY PREGNANCY SERUM AND AMNIOTIC-FLUID [J].
CLAUSSEN, M ;
ZAPF, J ;
BRAULKE, T .
ENDOCRINOLOGY, 1994, 134 (04) :1964-1966
[8]   THE INSULIN-LIKE GROWTH-FACTORS [J].
COHICK, WS ;
CLEMMONS, DR .
ANNUAL REVIEW OF PHYSIOLOGY, 1993, 55 :131-153
[9]  
CONOVER CA, 1994, J BIOL CHEM, V269, P7076
[10]   ENDOGENOUS CATHEPSIN D-MEDIATED HYDROLYSIS OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS IN CULTURED HUMAN PROSTATIC-CARCINOMA CELLS [J].
CONOVER, CA ;
PERRY, JE ;
TINDALL, DJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :987-993